Navigation Links
ShangPharma to Present at J.P. Morgan's 30th Annual Healthcare Conference
Date:12/14/2011

SHANGHAI, Dec. 14, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it will present at J.P. Morgan's 30th Annual Healthcare Conference, to be held in San Francisco from January 9-12, 2012.

Mr. Michael Xin Hui, founder and Chief Executive Officer of ShangPharma, and Mr. William Dai, Chief Financial Officer, will present at the conference.

Presentation materials will be available under the Webcasts & Presentations section of the Company's investor relations website at http://ir.shangpharma.com.

ABOUT SHANGPHARMA CORPORATION

ShangPharma Corporation (NYSE: SHP) is a leading China-based contract research organization providing high quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit www.shangpharma.com.

For further information, please contact:

ShangPharma
Ms. Lan Xie
VP of Finance and Investor Relations
Email: ir@shangpharma.com

Brunswick Group
Josh Gartner
Email: shangpharma@brunswickgroup.com
Phone: 86-10-5960-8600


'/>"/>
SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. ShangPharma Corp. to Announce Fourth Quarter and Full Year 2010 Financial Results on March 15, 2011
2. ShangPharma Announces First Quarter 2011 Results
3. ShangPharma Corporation Named a Top Ten Chinese Outsourcing Enterprise
4. ShangPharma Announces Second Quarter 2011 Results
5. ShangPharma Subsidiary and Jiangsu Hengrui Medicine Partner in Therapeutic Antibody Research and Development
6. InterMune to Present at Canaccord Adams Conference
7. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
8. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
9. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
10. Bionovo to Present at Canaccord Adams Global Growth Conference
11. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... MO (PRWEB) , ... June 28, 2017 , ... Supplies ... panel of leading experts gathered at the Society of Nuclear Medicine and Molecular Imaging ... isotope of technetium-99m (Tc-99m), which is used in 30 to 40 million nuclear medicine ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... powder activated carbon (PAC)-based materials do not have negative short- or long-term effects ... site contaminated with polychlorinated biphenyls (PCBs) located at the Puget Sound Naval Shipyard ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Workgroup for ... health IT to create efficiencies in healthcare information exchange and a statutory advisor to ... MD, head of the federal Office of the National Coordinator for Health Information Technology, ...
(Date:6/23/2017)... ... June 23, 2017 , ... DocCafe.com ... six of their healthcare job boards. As the largest network of professional ... and biotechnicians, DocCafe.com and the MedJobCafe.com Health Network work to match the ...
Breaking Biology Technology:
(Date:5/23/2017)... GENOA, Italy , May 23, 2017  Hunova, the first robotic ... and trunk, has been officially launched in Genoa, Italy ... Europe and the USA . The ... launched on the market by the IIT spin-off Movendo Technology thanks to ... view the Multimedia News Release, please click: ...
(Date:4/24/2017)... -- Janice Kephart , former 9/11 Commission ... LLP (IdSP) , today issues the following statement: ... 6, 2017 Executive Order: Protecting the Nation ... instilled with greater confidence, enabling the reactivation of ... are suspended by until at least July 2017). ...
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced Design ... will feature emerging and evolving technology through its ... Summits will run alongside the expo portion of the ... panels and demonstrations focused on trending topics within 3D ... design and manufacturing event will take place June 13-15, 2017 ...
Breaking Biology News(10 mins):